Human Immunodeficiency Virus Market Report- Growth with Industry Study, Detailed Analysis and Forecast to 2024

The Human Immunodeficiency Virus Market research reports provide industry dynamics and in-depth Human Immunodeficiency Virus Market segmentation with historical, current, and projected industry size along with industry trends. Furthermore, the Human Immunodeficiency Virus Market research report includes an in-depth market analysis utilizing Porter’s five force analysis and offers the impact of covid-19 on the market during the forecasted period.

Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4154754

Human immunodeficiency virus (HIV) is a retrovirus that attacks the immune system (NIH, 2020a). It infects, destroys, and impairs the cells of the immune system, mainly CD4-positive T-cells, which are key components of the cellular immune system (NIH, 2020a). Symptoms of HIV are similar to those of influenza, including fever, chills, muscle aches, and swollen lymph nodes (NIH, 2020b). If left untreated, HIV can progress into acquired immunodeficiency syndrome (AIDS) (NIH, 2016). HIV is primarily transmitted through bodily fluids (such as blood and semen) via unprotected anal or vaginal sex, as well as through sharing needles, syringes, or other drug injection equipment (WHO, 2020). It can also be passed from mother to child perinatally through pregnancy, childbirth, or breastfeeding (WHO, 2020).

RNR epidemiologists utilized comprehensive, country-specific HIV data from nationally representative public health surveillance systems and databases to arrive at a meaningful, in-depth epidemiological analysis and forecast for the total prevalence, diagnosed prevalence, and diagnosed incidence of HIV. Moreover, RNR epidemiologists provided detailed age- and sex segmentations, with additional segmentation by HBV coinfection, HCV coinfection, cases on ART, and the prophylactic population on PrEP. Finally, historical data were evaluated in all 7MM to strengthen the forecast by more accurately capturing changes in prevalence and incidence throughout the forecast period.

RNR epidemiologists forecast that the total prevalent cases of HIV in the 7MM will increase from 2,134,989 cases in 2019 to 2,332,792 cases in 2029. Furthermore, RNR epidemiologists forecast that the diagnosed prevalent cases of HIV in the 7MM will increase from 1,871,183 cases in 2019 to 2,068,647 cases in 2029. Finally, RNR epidemiologists forecast that the diagnosed incident cases of HIV in the 7MM will increase from 65,128 cases in 2019 to 64,204 cases in 2029.

Scope of this Report-
- The Human Immunodeficiency Virus (HIV) Epidemiology Report provides an overview of the risk factors, comorbidities, and global trends of HIV in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- The report includes a 10-year epidemiological forecast for the total prevalent cases of HIV, diagnosed prevalent cases of HIV, and diagnosed incident cases of HIV segmented by age (0-17 years, 18-29 years, and by 10-year age groups for age 30 years up to 80 years and older) and sex. Diagnosed prevalent cases are further segmented by coinfection with hepatitis B virus (HBV), coinfection with hepatitis C virus (HCV), and cases on antiretroviral therapy (ART). Lastly, the forecast includes the prophylactic population on pre-exposure prophylaxis (PrEP).
- The HIV epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in HIV.

Reasons to Buy this Report-
The HIV Epidemiology series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global HIV markets.
- Quantify patient populations in the global HIV markets to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for HIV therapeutics in each of the markets covered.
- Understand magnitude of the HIV population by age, sex, coinfection, and ART use.

Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=4154754

Table of Contents in this Report-
1.1 List of Tables
1.2 List of Figures
2 HIV: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.3.1 Total Prevalence of HIV
3.3.2 Diagnosed Prevalence of HIV
3.3.3 Diagnosed Incidence of HIV
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Sources Not Used
3.4.3 Forecast Assumptions and Methods
3.4.4 Total Prevalent Cases of HIV
3.4.5 Diagnosed Prevalent Cases of HIV
3.4.6 Diagnosed Prevalent Cases of HIV with HBV/HCV Coinfection
3.4.7 Diagnosed Prevalent Cases of HIV on ART
3.4.8 Diagnosed Incident Cases of HIV
3.4.9 Prophylactic Population on PrEP
3.5 Epidemiological Forecast for HIV (2019-2029)
3.5.1 Total Prevalent Cases of HIV
3.5.2 Diagnosed Prevalent Cases of HIV
3.5.3 Age-Specific Diagnosed Prevalent Cases of HIV
3.5.4 Sex-Specific Diagnosed Prevalent Cases of HIV
3.5.5 Diagnosed Prevalent Cases of HIV with Coinfection
3.5.6 Diagnosed Prevalent Cases of HIV on ART
3.5.7 Diagnosed Incident Cases of HIV
3.5.8 Age-Specific Diagnosed Incident Cases of HIV
3.5.9 Sex-Specific Diagnosed Incident Cases of HIV
3.5.10 Prophylactic Population on PrEP
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 COVID-19 Impact
3.6.3 Limitations of the Analysis
3.6.4 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
and more..

+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.